News about Global Pharma

Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs

Akeso Inc.'s partner, Summit Therapeutics, has entered a clinical trial collaboration with Pfizer to evaluate ivonescimab, a PD-1/VEGF bispecific antibody, in combination with Pfizer’s ADCs for multiple solid tumour treatments.

Global Pharma | 25/02/2025 | By Manvi |  367

GSK Completes Acquisition of IDRx

IDRX-42 has demonstrated activity against all clinically relevant primary and secondary KIT mutations, a key medical need in current GIST treatment.

Global Pharma | 25/02/2025 | By Aishwarya |  440

Pfizer Signs Marketing and Supply Deal with Mylan Pharmaceuticals

Under the terms of the agreement, Pfizer will retain ownership of the brands, while Mylan will be responsible for their marketing and sales within India for a period of five years.

Global Pharma | 25/02/2025 | By Aishwarya |  967

Evoke Pharma Welcomes Greg Pyszczymuka to Board of Directors

Pyszczymuka is a proven commercial leader with extensive experience in pharmaceutical sales, market access, and revenue growth. He currently serves as Chief Commercial Officer at Aytu BioPharma.

Global Pharma | 25/02/2025 | By Aishwarya |  157

Kineticos Launches Kinvard Bio to Power Next-Gen Antibiotics

KAMRA I is dedicated to combating antimicrobial resistance (AMR) by investing in, creating, and supporting companies that are developing disruptive solutions to address this critical public health issue.

Global Pharma | 25/02/2025 | By Aishwarya |  257

Co-Diagnostics Pulls 510(k) Application for PCR COVID-19 Test

Co-Diagnostics, Inc. announced that, following a collaborative and informative dialogue with the Food and Drug Administration (FDA), the Company has withdrawn its 510(k) application to the FDA for its Co-Dx™ PCR COVID-19 Test on the PCR Pro™, in favor of submitting an enhanced version of the test for 510(k) clearance.

Global Pharma | 24/02/2025 | By Manvi |  339

Zydus Secures USFDA Approval for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg

Zydus Lifesciences Ltd. has received final USFDA approval to manufacture Ibuprofen and Famotidine tablets (800 mg/26.6 mg) at its Ahmedabad facility.

Global Pharma | 24/02/2025 | By Manvi |  336

Indegene Develops Generative AI Platform Cortex for Life Sciences Sector

This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain, making medical writing more effective and efficient, and accelerating Medical-Legal-Regulatory (MLR) reviews.

Global Pharma | 24/02/2025 | By Aishwarya |  889

Granules India Expands into Peptide Therapeutics with Acquisition of Senn Chemicals

Senn Chemicals AG brings advanced expertise in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), along with an established customer base in pharmaceuticals, cosmetics, and theragnostic industries.

Global Pharma | 24/02/2025 | By Aishwarya |  920

MGI Tech to Advance Genomic Innovation in Oncological Health

The Oncoclínicas&Co has now another advanced technology for cancer diagnosis with the addition of the medium-throughput DNBSEQ-G400 genomic sequencer.

Global Pharma | 24/02/2025 | By Aishwarya |  203